Text and Data Mining valid from 2018-03-12
Received: 12 May 2017
Accepted: 19 February 2018
First Online: 12 March 2018
: C.S. and J.P.-L. are currently full-time employees at Biodol Therapeutics. P.S. serves as Chief Scientific Officer at Biodol Therapeutics. D.R. and J.V are inventors of patents claiming FLT3 inhibitors and their use for the treatment of neuropathic pain and are co-founders of Biodol Therapeutics. The remaining authors declare no competing interests.